Antares Pharma Inc (ATRS.OQ)
ATRS.OQ on NASDAQ Stock Exchange Capital Market
3.32USD
22 Aug 2019
3.32USD
22 Aug 2019
Change (% chg)
$0.01 (+0.30%)
$0.01 (+0.30%)
Prev Close
$3.31
$3.31
Open
$3.32
$3.32
Day's High
$3.33
$3.33
Day's Low
$3.31
$3.31
Volume
7,300
7,300
Avg. Vol
259,379
259,379
52-wk High
$3.96
$3.96
52-wk Low
$2.54
$2.54
Revenue & Earnings Per Share
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 31.72 | 32.67 | |
| P/E High - Last 5 Yrs. | -- | 39.41 | 47.29 | |
| P/E Low - Last 5 Yrs. | -- | 19.01 | 23.87 | |
| Beta | 0.28 | 0.80 | 0.89 | |
| Price to Sales (TTM) | 305.28 | 6.55 | 7.91 | |
| Price to Book (MRQ) | -- | 4.97 | 5.38 | |
| Price to Tangible Book (MRQ) | -- | 15.86 | 6.71 | |
| Price to Cash Flow (TTM) | -- | 21.52 | 24.37 | |
| % Owned Institutions | -- | 4.39 | 1.45 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.07 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.30 | 1.38 | |
| Dividend 5 Year Growth Rate | -- | 15.42 | 4.54 | |
| Payout Ratio(TTM) | -- | 31.06 | 40.24 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -64.35 | 8.74 | 12.23 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -42.76 | 2.10 | 7.74 | |
| Sales - 5 Yr. Growth Rate | -5.00 | 8.44 | 10.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -54.02 | 58.56 | 42.99 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -28.03 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 19.46 | 10.32 | |
| Capital Spending - 5 Yr. Growth Rate | 36.90 | 7.09 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.14 | 2.50 | 2.21 |
| Current Ratio (MRQ) | 0.22 | 3.22 | 3.03 |
| LT Debt to Equity (MRQ) | -- | 27.58 | 10.20 |
| Total Debt to Equity (MRQ) | -- | 34.65 | 14.55 |
| Interest Coverage (TTM) | -149.72 | 15.74 | 29.80 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 17.36 | 60.24 | 52.23 | |
| Gross Margin - 5 Yr. Avg. | 50.95 | 59.58 | 50.41 | |
| EBITD Margin (TTM) | -153.74 | -- | -- | |
| EBITD - 5 Yr. Avg | -110.22 | 23.20 | 13.13 | |
| Operating Margin (TTM) | -244.46 | 17.99 | 6.91 | |
| Operating Margin - 5 Yr. Avg. | -131.86 | 16.19 | 8.93 | |
| Pre-Tax Margin (TTM) | -244.96 | 17.85 | 6.12 | |
| Pre-Tax Margin - 5 Yr. Avg. | -125.55 | 16.52 | 9.23 | |
| Net Profit Margin (TTM) | -244.96 | 13.67 | 2.75 | |
| Net Profit Margin - 5 Yr. Avg. | -125.55 | 11.65 | 5.60 | |
| Effective Tax Rate (TTM) | -- | 23.07 | 22.40 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 28.49 | 22.74 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 53,082 | 27,860,118 | 887,152,306 | |
| Net Income/Employee (TTM) | -130,029 | 3,155,375 | 101,829,303 | |
| Receivable Turnover (TTM) | 10.46 | 5.09 | 5.93 | |
| Inventory Turnover (TTM) | 3.58 | 3.19 | 3.36 | |
| Asset Turnover (TTM) | 0.80 | 0.79 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -195.99 | 10.76 | 11.17 | |
| Return on Assets - 5 Yr. Avg. | -60.29 | 9.19 | 12.34 | |
| Return on Investment (TTM) | -- | 14.11 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | -76.85 | 11.84 | 16.02 | |
| Return on Equity (TTM) | -- | 16.67 | 15.78 | |
| Return on Equity - 5 Yr. Avg. | -79.39 | 14.09 | 17.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -42.76 | -18.76 | -5.00 |
| EPS (TTM) % | -28.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Antares Pharma Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 23.61 | 12.66 | 90 | 50 |
| 13 Week | 7.37 | -0.08 | 65 | 74 |
| 26 Week | 2.42 | 16.39 | 43 | 63 |
| 52 Week | 38.61 | 55.81 | 77 | 47 |
| YTD | 2.36 | -4.98 | 34 | 44 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.